MSB
Click for more information
0.32% 77.3¢ mesoblast limited

Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    17/12/19
    09:49
    Post #: 42002770
    Likes Created with Sketch. 28  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

BGD Barton kicks off scoping studies at Tunkillia – a 1.5Moz gold play
right-arrow Created with Sketch.
RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
WGX Bluebird-South Junction soars 134% higher in resource for Westgold
right-arrow Created with Sketch.
MGU Magnum pushes Saudi pig iron project further down the road to Nevada
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
77.3¢ 		Change
-0.003(0.32%) 		Mkt cap ! $887.7M
Open High Low Value Volume
76.5¢ 80.3¢ 76.0¢ $4.120M 5.298M

Buyers (Bids)

No. Vol. Price($)
17 133435 77.0¢
 

Sellers (Offers)

Price($) Vol. No.
77.5¢ 57915 13
View Market Depth
Last trade - 15.03pm 19/04/2024 (20 minute delay) ?
Last
77.3¢ 		  Change
-0.003 ( 0.23 %)
Open High Low Volume
78.0¢ 80.0¢ 76.0¢ 1899273
Last updated 15.24pm 19/04/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.